Small extracellular vesicles engineered using click chemistry show promise for targeting liver failure
A study conducted by Prof. Thai-Yen Ling at National Taiwan University underscores the potential of small extracellular ...
EurekAlert!2d
A 3D bone marrow analog reveals the role of trabecular volume in MSC mechanoresponse and bone loss during aging and microgravity
Aged individuals and astronauts experience bone loss despite rigorous physical activity. Bone mechanoresponse is in-part ...
Mesoblast announces it entered into NDRA with CMS DHHS for Ryoncil
Mesoblast (MESO) announced that it has entered into the Medicaid National Drug Rebate Agreement, NDRA, with the U.S. Centers for Medicare & ...
eLife5d
Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines
Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.
First Three Children to Commence Treatment With Ryoncil®
Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...